Infective and Thrombotic Complications of Central Venous Catheters in Patients with Hematological Malignancy: Prospective Evaluation of Nontunneled Devices

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2008 Dec 20

PMID 19096883

Citations 30

Authors

Leon J Worth

John F Seymour

Monica A Slavin

Affiliations

Soon will be listed here.

Abstract

Goals: Central venous catheter (CVC)-related bloodstream infection (CR-BSI) is a significant complication in hematology patients. A range of CVC devices may be used, and risks for the development of complications are not uniform. The objectives of this study were to determine the natural history and rate of CVC-related complications and risk factors for CR-BSI and to compare device-specific complications in a hematology population.

Patients And Methods: An observational cohort of patients with hematologic malignancy was prospectively studied following CVC insertion. Participants were reviewed until a CVC-related complication necessitated device removal, completion of therapy, death, or defined end-of-study date. The National Nosocomial Infection Surveillance definition for CR-BSI was used. Overall and device-specific rates of infective and noninfective complications were calculated and potential risk factors were captured.

Main Results: One hundred six CVCs (75 peripherally inserted central venous catheters [PICCs], 31 nontunneled CVCs) were evaluated in 66 patients, over 2,399 CVC days. Thrombosis occurred in 16 cases (15.1%), exit-site infection in two (1.9%), and CR-BSI in 18 (7.5 per 1,000 CVC days). No significant differences were found when complication rates in PICC and nontunneled devices were compared. An underlying diagnosis of acute myeloid leukemia was negatively associated with CR-BSI (odds ratio (OR) 0.14, p = 0.046), and a previous diagnosis of fungal infection was associated with infection (OR 22.82, p = 0.031).

Conclusions: CR-BSI rates in our hematology population are comparable to prior reports. A low rate of exit-site infection and high proportion of thrombotic complications were observed. No significant differences in thrombotic or infective complications were evident when PICC and nontunneled devices were compared. PICC devices are a practical and safe option for management of hematology patients.

Citing Articles

Antibiotic lock therapy for the treatment of peripherally inserted central venous catheter-related bloodstream infection in patients with hematological malignancies: a single center retrospective study.

Zhang Q, Huo Y, Li C, Sun Q, Xi X, Sun R Ann Hematol. 2025; .

PMID: 39998671 DOI: 10.1007/s00277-025-06263-8.

Prevalence of PICC-related thrombosis in patients with hematological malignancies: a systematic review.

Dos Santos B, Gomes Beato B, Ferreira E, Braga F, Reis P, Silveira R Support Care Cancer. 2024; 32(7):462.

PMID: 38922487 DOI: 10.1007/s00520-024-08636-7.

Investigation of risk factors for tunneled hemodialysis catheters dysfunction: competing risk analysis of a tertiary center data.

Mohazzab A, Khavanin Zadeh M, Dehesh P, Abdolvand N, Rahimi Z, Rahmani S BMC Nephrol. 2022; 23(1):300.

PMID: 36056311 PMC: 9440495. DOI: 10.1186/s12882-022-02927-z.

The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: A systematic review and meta-analysis.

Puri A, Dai H, Giri M, Wu C, Huang H, Zhao Q Front Cardiovasc Med. 2022; 9:917572.

PMID: 35958406 PMC: 9360324. DOI: 10.3389/fcvm.2022.917572.

Indwelling time of peripherally inserted central catheters and incidence of bloodstream infections in haematology patients: a cohort study.

Caris M, de Jonge N, Punt H, Salet D, de Jong V, Lissenberg-Witte B Antimicrob Resist Infect Control. 2022; 11(1):37.

PMID: 35177128 PMC: 8851849. DOI: 10.1186/s13756-022-01069-z.

References

Wisplinghoff H, Cornely O, Moser S, Bethe U, Stutzer H, Salzberger B . Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study. Infect Control Hosp Epidemiol. 2004; 24(12):905-11. DOI: 10.1086/502158. View

Celebi H, Akan H, Akcaglayan E, Ustun C, Arat M . Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant. 2000; 26(2):211-4. DOI: 10.1038/sj.bmt.1702503. View

Solomon B, Moore J, Arthur C, Prince H . Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. Eur J Cancer. 2001; 37(18):2379-84. DOI: 10.1016/s0959-8049(01)00320-3. View

ALLEN A, Megargell J, Brown D, Lynch F, Singh H, Singh Y . Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol. 2000; 11(10):1309-14. DOI: 10.1016/s1051-0443(07)61307-4. View

Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J . Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med. 1993; 153(15):1791-6. View

Worth L, Slavin M, Brown G, Black J . Catheter-related bloodstream infections in hematology: time for standardized surveillance?. Cancer. 2007; 109(7):1215-26. DOI: 10.1002/cncr.22527. View

Maki D, Kluger D, Crnich C . The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81(9):1159-71. DOI: 10.4065/81.9.1159. View

Worth L, Slavin M, Black J . Bloodstream infections in a secondary and tertiary care hospital setting. Intern Med J. 2007; 37(4):284-5. DOI: 10.1111/j.1445-5994.2007.01327.x. View

Safdar N, Maki D . Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005; 128(2):489-95. DOI: 10.1378/chest.128.2.489. View

10.

Axnick K . Infection control considerations in the care of the immunosuppressed patient. CCQ. 1980; 3:79-88. View

11.

Grove J, Pevec W . Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000; 11(7):837-40. DOI: 10.1016/s1051-0443(07)61797-7. View

12.

Mermel L, Farr B, Sherertz R, Raad I, OGrady N, Harris J . Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32(9):1249-72. DOI: 10.1086/320001. View

13.

Masci G, Magagnoli M, Pedicini V, Poretti D, Castagna L, Carnaghi C . Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications. Support Care Cancer. 2006; 14(11):1141-6. DOI: 10.1007/s00520-006-0065-2. View

14.

Dettenkofer M, Wenzler-Rottele S, Babikir R, Bertz H, Ebner W, Meyer E . Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis. 2005; 40(7):926-31. DOI: 10.1086/428046. View

15.

Penney-Timmons E, Sevedge S . Outcome data for peripherally inserted central catheters used in an acute care setting. J Infus Nurs. 2004; 27(6):431-6. DOI: 10.1097/00129804-200411000-00009. View

16.

Boersma R, Jie K, Verbon A, van Pampus E, Schouten H . Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol. 2007; 19(3):433-42. DOI: 10.1093/annonc/mdm350. View

17.

Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U . Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant. 2003; 31(9):795-801. DOI: 10.1038/sj.bmt.1703920. View

18.

James L, Bledsoe L, Hadaway L . A retrospective look at tip location and complications of peripherally inserted central catheter lines. J Intraven Nurs. 1993; 16(2):104-9. View

19.

Harter C, Ostendorf T, Bach A, Egerer G, Goldschmidt H, Ho A . Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies. Support Care Cancer. 2003; 11(12):790-4. DOI: 10.1007/s00520-003-0517-x. View

20.

Horan T, Emori T . Definitions of key terms used in the NNIS System. Am J Infect Control. 1997; 25(2):112-6. DOI: 10.1016/s0196-6553(97)90037-7. View